Growth-inhibitory effects of artesunate, pyrimethamine, and pamaquine against Babesia equi and Babesia caballi in in vitro cultures

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 2, 2003, Pages 800-803

  Nagai, Akiko ^a   Yokoyama, Naoaki ^a   Matsuo, Tomohide ^a   Bork, Sabine ^a   Hirata, Haruyuki ^a   Xuan, Xuenan ^a   Zhu, Yinchang ^b   Claveria, Florencia G ^a   Fujisaki, Kozo ^a   Igarashi, Ikuo ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTIPROTOZOAL AGENT; ARTESUNATE; PAMAQUINE; PYRIMETHAMINE;

ANTIPROTOZOAL ACTIVITY; ARTICLE; BABESIA CABALLI; BABESIA EQUI; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG MECHANISM; GROWTH INHIBITION; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; PROTOZOAL INFECTION;

AMINOQUINOLINES; ANIMALS; ANTIMALARIALS; ARTEMISININS; BABESIA; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; PYRIMETHAMINE; SESQUITERPENES;

EID: 0037310255     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.2.800-803.2003     Document Type: Article

References (21)

1. Avarzed, A., I. Igarashi, T. Kanemaru, K. Hirumi, Y. Omata, A. Saito, T. Oyamada, H. Nagasawa, Y. Toyoda, and N. Suzuki. 1997. Improved in vitro cultivation of Babesia caballi. J. Vet. Med. Sci. 59:479-481.
2. Brockelman, C., and P. Tan-ariya. 1991. Development of an in vitro microtest to assess drug susceptibility of Babesia bovis and Babesia bigemina. J. Parasitol. 77:994-997.
3. Brockman, A., R. N. Price, M. van Vugt, D. G. Heppner, D. Walsh, P. Sookto, T. Wimonwattrawatee, S. Looareesuwan, N. J. White, and F. Nosten. 2000. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Trans. R. Soc. Trop. Med. Hyg. 94:537-544.
4. Brüning, A. 1996. Equine piroplasmosis an update on diagnosis, treatment and prevention. Br. Vet. J. 152:139-151.
5. Fidock, D. A., and T. E. Wellems. 1997. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR 992210 but does not affect the intrinsic activity of proguanil. Proc. Natl. Acad. Sci. USA 94:10931-10936.
6. Geary, T. G., A. A. Divo, and J. B. Jensen. 1987. Activity of quinoline-containing antimalarials against chloroquine-sensitive and -resistant strains of Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 81:499-503.
7. Hagiwara, K., M. Tsuji, C. Ishihara, M. Tajima, T. Kurosawa, H. Iwai, and K. Takahashi. 1993. The Bo-RBC-SCID mouse model for evaluating the efficacy of anti-theilerial drugs. Int. J. Parasitol. 23:13-16.
8. Igarashi, I., F. K. Njonge, Y. Kaneko, and Y. Nakamura. 1998. Babesia bigemina: in vitro and in vivo effects of curdlan sulfate on growth of parasites. Exp. Parasitol. 90:290-293.
9. Ittarat, W., R. Udomsangpeth, K. T. Chotivanich, and S. Looareesuwan. 1999. The effects of quinine and artesunate treatment on plasma tumor necrosis factor levels in malaria-infected patients. Southeast Asian J. Trop. Med. Public Health 30:7-10.
10. Kawai, S., I. Igarashi, A. Avarzed, K. Miyazawa, H. Ikadai, H. Nagasawa, K. Fujisaki, T. Mikami, N. Suzuki, and H. Matsuda. 1999. Ultrastructural characteristics of Babesia caballi in equine erythrocytes in vitro. Parasitol. Res. 85:794-799.
11. Kuttler, K. L., J. L. Zaugg, and C. A. Gipson. 1987. Imidocarb and parvaquone in the treatment of piroplasmosis (Babesia equi) in equids. Am. J. Vet. Res. 48:1613-1616.
12. Lanners, H. N. 1991. Effect of the 8-aminoquinoline primaquine on culture-derived gametocytes of the malaria parasite Plasmodium falcipalm. Parasitol. Res. 77:478-481.
13. Meshnick, S. R., T. E. Taylor, and P. Kamchonwongpaisan. 1996. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol. Rev. 60:301-315.
14. Nott, S. E., and A. S. Bagnara. 1993. The toxicity of antifolates in Babesia bovis. Int. J. Parasitol. 23:399-402.
15. Olenick, J. G. 1975. Primaquine, p. 516-520. In J. W. Corcoran and F. E. Hahn (ed.), Antibiotics III: mechanism of action of anti-microbial and antitumor agents. Springer-Verlag, New York, N.Y.
16. Olliaro, P. L., R. K. Haynes, B. Meunier, and Y. Yuthavong. 2001. Possible modes of action of the artemisinin-type compounds. Trends Parasitol. 17: 122-126.
17. Reynolds, M. G., J. Oh, and D. S. Roos. 2001. In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase. Antimicrob. Agents Chemother. 45:1271-1277.
18. Schein, E. 1988. Equine babesiosis, p. 197-208. In M. Ristic (ed.), Babesiosis of domestic animals and man. CRC Press, Boca Raton, Fla.
19. van Weert, A. W., H. J. Geuze, B. Groothuis, and W. Stoorvogel. 2000. Primaquine interferes with membrane recycling from endosomes to the plasma membrane through a direct interaction with endosomes which does not involve neutralisation of endosomal pH nor osmotic swelling of endosomes. Eur. J. Cell Biol. 79:394-399.
20. Vennerstrom, J. L., E. O. Nuzum, R. E. Miller, A. Dorn, L. Gerena, P. A. Dande, W. Y. Ellis, R. G. Ridley, and W. K. Milhous. 1999. 8-Aminoquinolines active against blood stage Plasmodium falciparum in vitro inhibit hematin polymerization. Antimicrob. Agents Chemother. 43:598-602.
21. Zaugg, J. L., and V. M. Lane. 1992. Efficacy of buparvaquone as a therapeutic and clearing agent of Babesia equi of European origin in horses. Am. J. Vet. Res. 53:1396-1399.